Assignee
CARDURION PHARMACEUTICALS LLC
US·5 granted patents·3 pending applications·10 citations·filing 2018–2021
Top patents by PatentIndex Score
8 records- 0191US10543212B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2018·Granted Jan 28, 2020·10 cites·11 claims
- 0265US10870656B2Methods for treatment of heart failureCARDURION PHARMACEUTICALS LLC·Filed 2019·Granted Dec 22, 2020·0 cites·9 claims
- 0362US2022112184A1Aminopyrimidine compoundCARDURION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0461US11130752B2Aminopyrimidine compoundCARDURION PHARMACEUTICALS LLC·Filed 2019·Granted Sep 28, 2021·0 cites·5 claims
- 0561US10822346B2Meglumine salts of thienopyrimidinesCARDURION PHARMACEUTICALS LLC·Filed 2019·Granted Nov 3, 2020·0 cites·21 claims
- 0658US2021261567A1Methods for treatment of heart failureCARDURION PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 0755US11197858B2Substituted amines for treating cardiac diseasesCARDURION PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·8 claims
- 0851US2021139499A1Meglumine salts of thienopyrimidinesCARDURION PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →